Literature DB >> 18640581

Alternate pathway of entry of budded Autographa californica nuclear polyhedrosis virus: fusion at the plasma membrane.

L E Volkman1, P A Goldsmith, R T Hess.   

Abstract

Recently we reported that the budded phenotype of Autographa californica nuclear polyhedrosis virus (AeNPV BV) functionally entered IPLB-SF-21 cells by adsorptive endocytosis and that neutralizing monoclonal antibody AcV1 acted by preventing AcNPV BV from using this entry pathway (L. E. Volkman and P. A. Goldsmith (1985), Virology 143, 185-195). Not all infectivity could be neutralized by AcV1, however, and in the study reported herein we investigated the nature of the particles responsible for this residual infectivity, and obtained evidence for an alternate entry pathway for both AcNPV BV and AcV1 treated BV. Residual infectivity was shown to be due to AcV1 linked AcNPV BV and not aberrant particles lacking the AcV1-reactive BV epitope. We obtained evidence that entry by fusion at the plasma membrane, but not phagocytosis, appeared to be an additional, functionally less efficient entry pathway. Fusion was indicated by the detection of viral envelope antigen in the host cell plasma membrane by immunoelectron microscopy. Fusion occurred even at 4 degrees , which was unexpected and highly unusual. Treatment of cells with cytochalasin B inhibited phagocytosis but did not reduce BV infectivity.

Entities:  

Year:  1986        PMID: 18640581     DOI: 10.1016/0042-6822(86)90326-0

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  10 in total

1.  Replication patterns and cytopathology of cells infected with baculoviruses.

Authors:  G V Williams; P Faulkner
Journal:  Cytotechnology       Date:  1996-01       Impact factor: 2.058

2.  Evidence for endocytosis-independent infection by human rotavirus.

Authors:  N Fukuhara; O Yoshie; S Kitaoka; T Konno; N Ishida
Journal:  Arch Virol       Date:  1987       Impact factor: 2.574

3.  Dissecting the Cell Entry Pathway of Baculovirus by Single-Particle Tracking and Quantitative Electron Microscopic Analysis.

Authors:  Fujun Qin; Congrui Xu; Jia Hu; Chengfeng Lei; Zhenhua Zheng; Ke Peng; Hanzhong Wang; Xiulian Sun
Journal:  J Virol       Date:  2019-04-03       Impact factor: 5.103

4.  Autographa californica multicapsid nucleopolyhedrovirus efficiently infects Sf9 cells and transduces mammalian cells via direct fusion with the plasma membrane at low pH.

Authors:  Sicong Dong; Manli Wang; Zhijuan Qiu; Fei Deng; Just M Vlak; Zhihong Hu; Hualin Wang
Journal:  J Virol       Date:  2010-03-10       Impact factor: 5.103

5.  Infected cell specific protein and viral DNA synthesis in productive and abortive infections of Spodoptera frugiperda nuclear polyhedrosis virus.

Authors:  H S Liu; S L Bilimoria
Journal:  Arch Virol       Date:  1990       Impact factor: 2.574

6.  The function of envelope protein P74 from Autographa californica multiple nucleopolyhedrovirus in primary infection to host.

Authors:  Wenke Zhou; Lunguang Yao; Hua Xu; Feng Yan; Yipeng Qi
Journal:  Virus Genes       Date:  2005-03       Impact factor: 2.332

7.  Structured modeling of recombinant protein production in batch and fed-batch culture of baculovirus-infected insect cells.

Authors:  J D Jang; C S Sanderson; L C Chan; J P Barford; S Reid
Journal:  Cytotechnology       Date:  2000-10       Impact factor: 2.058

8.  Biochemical analysis of Hyphantria cunea NPV attachment to Spodoptera frugiperda 21 cells.

Authors:  J O Park; K H Chang; H H Lee; I S Chung
Journal:  Cytotechnology       Date:  1999-09       Impact factor: 2.058

9.  Autographa Californica Multiple Nucleopolyhedrovirus Enters Host Cells via Clathrin-Mediated Endocytosis and Direct Fusion with the Plasma Membrane.

Authors:  Fujun Qin; Congrui Xu; Chengfeng Lei; Jia Hu; Xiulian Sun
Journal:  Viruses       Date:  2018-11-14       Impact factor: 5.048

Review 10.  Virus entry into animal cells.

Authors:  M Marsh; A Helenius
Journal:  Adv Virus Res       Date:  1989       Impact factor: 9.937

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.